Endometrial cancer begins when the cells of the inner lining of the uterus, known as the endometrium, become malignant. It is the most common type of cancer in the uterus and is divided into different types based on cell histology.
Patients with endometriosis face significantly higher risks of postoperative complications when undergoing surgery for stage I endometrial cancer, according to a new study presented at the Society of...
A recent clinical trial on adjuvant therapy for endometrial cancer investigated the impact of pembrolizumab on disease-free survival. But which patient population saw the most significant benefit? Test your...
Researchers recently published a survey that aimed at evaluating public awareness of postmenopausal bleeding as a symptom of endometrial cancer. Do you know the survey findings? Test your knowledge with...
Read our Q&A with Megan Clarke, PhD, MHS, about the role of postmenopausal bleeding in the early detection of endometrial cancer. Then take this quiz to see what you've learned!
In this video, Brian M. Slomovitz, MD, discusses his recent study demonstrating a significant improvement in disease-free survival with pembrolizumab in patients with dMMR endometrial cancer. He explains...
In this video, Anna Jo Smith, MD, MPH, MSc, discusses the use of two FDA-approved immunotherapy treatments for endometrial cancer in patients. She talks about health care disparities surrounding the...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
In this video, Stephanie V. Blank, MD, and Warner K. Huh, MD, discuss the evolving role of the gynecologic oncologist, including the use of chemotherapy, benign surgery, and the management of patients with...
